arrow
Back
R

Rajshekhar Chakraborty

columbia university irving medical center

27H-index
294Paper Count
2.7KCitation Count
Published Papers 90
Publication Date
Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma
err2026-08-22
err0
errOAAI
errMansi R. Shah; Aishee Bag; Asis Shrestha; Yetunde Ogunsesan; Anup Trikannad; Sruthi Vellanki; Sanjay Muttineni; Hira Cheema; Syed Naqvi; Sasya Dronavalli; Samer Al Hadidi; Sharmilan Thanendrarjan; Maurizio Zangari; Frits van Rhee; Aniko Szabo; Rajshekar Chakraborty; Meera Mohan; Carolina Schinke
errShare
errSave
A Clinically Applicable Conversion Formula between NT-proBNP and BNP in Light-Chain Amyloidosis
err2026-07-20
err0
errOAAI
errEli Muchtar; Allan S. Jaffe; Andrew Staron; Vaishali Sanchorawala; Heather Landau; Oren Pasvolsky; Rajshekhar Chakraborty; Suzanne Lentzsch; Morie A. Gertz; Angela Dispenzieri
errShare
errSave
Sustained disease remission after a limited duration of bispecific antibody therapy in patients with multiple myeloma
err2026-06-07
err0
errOAAI
errGala Vega; Daniel Morillo; Christine Riedhammer; Febe Smits; Aishee Bag; Kelly Julian; Natalia Tovar Gomis; Carmen Montes Gaisan; Maria Aranzazu Bermudez; Mansi R. Shah; Ghulam Rehman Mohyuddin; Binod Dhakal; Leo Rasche; Carolina Schinke; Anita D'Souza; Aniko Szabo; Niels W. C. J. van de Donk; Rajshekhar Chakraborty; Meera Mohan
errShare
errSave
Use of CD38 antibodies in high-risk newly diagnosed Multiple Myeloma – A meta-analysis
err2026-04-30
err0
PREAI
errDivaya Bhutani; Yusha Liu; Rajshekhar Chakraborty; Michael Hughes; Suzanne Lentzsch; Samuel Rubinstein
errShare
errSave
Disease Prognosis and Progression in Transthyretin Amyloidosis
err2026-04-21
err0
errOAAI
errJoban Vaishnav; Dimitrios Bampatsias; Brian C. Boursiquot; Yevgeniy Brailovsky; Kristin Hsu; Jamie Zigterman; Rajshekhar Chakraborty; Ashutosh Wechalekar; Pablo Garcia Pavia; Ronald Witteles; Mazen Hanna; Chafic Karam; Mathew S. Maurer; Jan M. Griffin
errShare
errSave
The Association of Age and Frailty With Adverse Events for Bortezomib and Carfilzomib: A Population-Based Analysis
err2026-04-01
err0
PREAI
errLemieux, Mackenzie; Chunara, Farheen; Szabo, Aniko; Van Oekelen, Oliver; Chakraborty, Rajshekhar; Godara, Amandeep; Shaikh, Hira; Strouse, Christopher; Mohan, Meera; Mohyuddin, Ghulam Rehman
errShare
errSave
Predicting Early Mortality in Newly Diagnosed AL Amyloidosis: Development and Validation of the PACE Score for Daratumumab-Treated Patients
err2026-03-07
err0
PREAI
errGeorge S. Mellgard; Abdul-Hamid Bazarbachi; Saurabh Zanwar; Ute Hengenbart; Geethika Bodanapu; Divaya Bhutani; GuiZhen Chen; Anita D’Souza; Angela Dispenzieri; Morie Gertz; Shaji Kumar; Suzanne Lentzsch; Paolo Milani; Eli Muchtar; Giovanni Palladini; Despina Trajanova; Anannya Patwari; Vaishali Sanchorawala; Mohamad Mohty; Shikun Wang; Efstathios Kastritis; Foteini Theodorakakou; Stefan Schönland; Rajshekhar Chakraborty; Andrew J. Cowan
errShare
errSave
Prognostic Factors and Progression Biomarkers in AL Amyloidosis: Mapping Current Knowledge and Critical Gaps
errBlood
IF23.1
err2026-03-06
err0
errOAAI
errRajshekhar Chakraborty; Yevgeniy Brailovsky; Mazen Hanna; Ron Witteles; Joban Vaishnav; James Edward Hoffman; Jan Griffin; Pablo Garcia-Pavia; David Wolinsky; Chafic Karam; Helen Lachmann; Morie Gertz; Brian Boursiquot; Dimitrios Bampatsias; Kristen Hsu; Phaedra Johnson; Jamie Zigterman; Ana Carolina Kazemzadeh; Mathew S. Maurer; Ashutosh Wechalekar
errShare
errSave
Non-ICANS neurological toxicities associated with BCMA-directed CAR T-cell therapy in patients with plasma cell dyscrasia: A systematic review and pooled analysis
err2026-02-18
err0
PREAI
errManpreet Saini; F. N. U. Deeksha; Aditya Jandial; Arihant Jain; Gaurav Prakash; Alka Khadwal; Rajshekhar Chakraborty; Pankaj Malhotra; Charanpreet Singh
errShare
errSave
Inconsistent definitions of transplant ineligibility in multiple myeloma: A systematic review
err2026-01-01
err0
errOAAI
errNeupane, Karun; Singstock, Mitch; Shah, Darshi; Dahal, Riyasha; Mian, Hira; Smith, Febe; Chakraborty, Rajshekhar; Al Hadidi, Samer; Mainou, Maria; Grajales-cruz, Ariel; Naqvi, Syeda Mahrukh Hussnain; Shain, Kenneth H.; Goodman, Aaron; Costa, Luciano J.; Qazilbash, Muzaffar; Mohyuddin, Ghulam Rehman
errShare
errSave
Kinetics of hematologic response in AL amyloidosis: Insights from clinical and cytogenetic subgroup analysis in the daratumumab era
err2025-12-28
err0
errOAAI
errBazarbachi, Abdul-hamid; Zanwar, Saurabh; Hegenbart, Ute; Trajanova, Despina; Bhutani, Divaya; Gertz, Morie A.; Dispenzieri, Angela; Kumar, Shaji; D'souza, Anita; Patwari, Anannya; Cowan, Andrew; Chen, Guizhen; Milani, Paolo; Palladini, Giovanni; Sanchorawala, Vaishali; Bodanapu, Geethika; Mohty, Mohamad; Lentzsch, Suzanne; Schonland, Stefan O.; Muchtar, Eli; Chakraborty, Rajshekhar
errShare
errSave
CAR T-cells in multiple myeloma: the race to the start line
err2025-12-27
err0
PREAI
errAbdul-Hamid Bazarbachi; Divaya Bhutani; Michael Sang Hughes; Suzanne Lentzsch; Markus Mapara; Pawel Muranski; Ran Reshef; Tamna Wangjam; Rajshekhar Chakraborty
errShare
errSave
Why We Do Not Recommend That People With High-Risk Smoldering Myeloma Receive Treatment
err2025-12-01
err0
errOAAI
errMohyuddin, Ghulam Rehman; Lemieux, Mackenzie; Chakraborty, Rajshekhar; Gertz, Morie
errShare
errSave
Optimizing oncology drug development: systematic review of 22 years of myeloma randomized controlled trials
err2025-11-09
err0
errOAAI
errMaria Mainou, MD; Muatassem Alsadhan, MD; Kalliopi Tsapa, MD; Alissa Visram, MD; Hira Mian, MD; Rakesh Popat, MD; Elias K Mai, MD; Rajshekhar Chakraborty, MD; Samer Al Hadidi, MD; Meera Mohan, MD; Aniko Szabo, PhD; Oliver Van Oekelen, MD; Edward R Scheffer Cliff, MBBS; Ghulam Rehman Mohyuddin, MD
errShare
errSave
Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study
err2025-11-07
err0
errOAAI
errSamer Al Hadidi; Aniko Szabo; Bhavesh Mohan Lal; Aishee Bag; Simon Zhen; Yetunde Ogunsesan; Evanka Annyapu; Binod Dhakal; Divaya Bhutani; Sharmilan Thanendrarajan; Maurizio Zangari; Anita D’Souza; Suzanne Lentzsch; Frits van Rhee; Rajshekhar Chakraborty; Carolina Schinke; Meera Mohan; Mansi R. Shah
errShare
errSave
Treatment response assessment using whole body diffusion weighted-magnetic resonance imaging in myeloma: a retrospective cohort study
err2025-11-01
err0
PREAI
errChakraborty, Rajshekhar; Shalaby, Khalid; Parker, Sarah; Lala, Sonali; Beylergil, Volkan; Alberico, Ronald; Bhutani, Divaya; Hillengass, Jens; Lentzsch, Suzanne
errShare
errSave
Contextualizing results of randomized trials in smoldering myeloma
err2025-09-01
err0
PREAI
errMohyuddin, Ghulam Rehman; Goodman, Aaron M.; Chakraborty, Rajshekhar
errShare
errSave
Real-World Outcomes of Transplant Ineligible Older Adults With Multiple Myeloma Treated With Novel Regimens: A Population-Based Retrospective Cohort Study
err2025-08-29
err0
PREAI
errNadine Abdallah; Hira Mian; Hsien Seow; Gregory P. Pond; Anastasia Gayowsky; Alissa Visram; Luciano J. Costa; Tanya M. Wildes; Rafael Fonseca; Charlotte Pawlyn; Gordon Cook; Shaji Kumar; Rajshekhar Chakraborty
errShare
errSave
Safety and efficacy of elranatamab in patients with daratumumab relapsed and/or refractory immunoglobulin light-chain amyloidosis
errBlood
IF23.1
err2025-07-28
err0
PREAI
errPedro Vianna; Rajshekhar Chakraborty; Shahrier Hossain; Divaya Bhutani; Shannon Miller; Annemarie Rossi; Sarah A. M. Cuddy; Rodney H. Falk; Suzanne Lentzsch; Jacob P. Laubach; Giada Bianchi
errShare
errSave